Pharmaceutical firms reluctant to spend on R&D

Published: 2011-08-26 07:00:00

Updated: 2011-08-26 07:00:00

A total of 30 pharmaceutical companies that chalked up the combined sales of over 3.8 trillion won for the first half of this year, invested 240.3 billion won in research, an average 6.3 percent of their revenue.

Yakup.com. says that 30 firms listed on the main bourse, excluding Hanmi Pharmace...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK